Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

One of the most frightening things about Alzheimer's disease is how difficult it is to diagnose early. Now, University of ...

Science minister Sir Patrick Vallance said he was "super excited" by advancements in dementia diagnosis and treatment ...

Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early ...

A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...

A new research paper documents the outcomes of five volunteers who continued to receive 40Hz light and sound stimulation for ...

Joanna Fix and Forrest Fix of Colorado Springs talk about living with Alzheimer's disease. They say it's all about learning how to live with it, not die from it.

Village Caregiving reports that frontotemporal dementia is a progressive brain disease affecting behavior, speech, and memory ...

The Justice Department unexpectedly dropped charges against a neuroscientist indicted for defrauding the NIH of approximately ...

They were enjoying traveling the world when she was struck by early-onset Alzheimer’s disease. Now, the Summerville couple ...

In Canada, lecanemab is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment or mild dementia due to Alzheimer’s disease (early AD) who are apolipoprote ...

One million people in the UK currently live with dementia and this number is expected to rise to 1.4 million by 2040.